Type 2 diabetes can go into remission, but it requires significant, sustained changes to your body’s metabolism. The medical consensus defines remission as maintaining an HbA1c below 6.5% for at least three months without taking any glucose-lowering medication. That’s an achievable goal for many people, especially those diagnosed within the last few years. Type 1 diabetes, which involves a different disease process entirely, cannot currently be reversed, though new therapies are getting closer than ever.
The distinction matters: remission is not the same as a cure. The underlying tendency toward insulin resistance can return, particularly if weight is regained. But for many people with Type 2 diabetes, the right combination of weight loss, dietary change, exercise, and sometimes surgery can restore blood sugar control to the point where medication is no longer necessary.
What Actually Goes Wrong (and What Can Be Fixed)
Type 2 diabetes develops when fat accumulates inside two organs that aren’t designed to store much of it: the liver and the pancreas. Excess fat in the liver makes it resistant to insulin, so it keeps dumping sugar into your blood even when levels are already high. Meanwhile, fat buildup in the pancreas gradually poisons the cells that produce insulin, weakening their ability to respond when blood sugar rises after a meal.
Research from Newcastle University demonstrated that this process is reversible. When participants followed a calorie-restricted diet, fat levels in both organs dropped significantly. Pancreatic fat fell from about 8% to 6.2%, and the insulin-producing cells began working again. Their first-phase insulin response, the quick burst of insulin your body releases right after eating, more than doubled and approached the levels seen in people without diabetes. The takeaway: if you reduce the fat clogging these two organs, the underlying machinery can start functioning normally again.
Weight Loss Is the Strongest Lever
The single most predictive factor for achieving remission is how much weight you lose. A large community-based study found that people who lost 10% or more of their body weight within the first year of diagnosis were roughly twice as likely to achieve remission compared to those who maintained the same weight. That benefit persisted at the five-year mark as well, where 10% weight loss more than doubled remission odds. For someone weighing 220 pounds, that means losing at least 22 pounds and keeping it off.
Losing weight earlier in the disease course matters. The longer you’ve had diabetes, the more damage accumulates in the insulin-producing cells of the pancreas, and at some point that damage becomes irreversible. People diagnosed within the last six years tend to respond best to weight-loss interventions.
The Low-Calorie Diet Approach
The most rigorously tested dietary protocol for diabetes remission is the DiRECT trial’s total diet replacement program. Participants consumed 825 to 853 calories per day using nutritionally complete liquid meal replacements (soups and shakes) for 12 to 20 weeks, replacing all regular food. After the intensive phase, they transitioned gradually back to a food-based diet with individually tailored calorie targets designed to prevent weight regain.
This is not a long-term eating pattern. It’s a short, aggressive intervention meant to rapidly drain fat from the liver and pancreas, followed by a sustainable maintenance diet. The protocol produced remission in a significant portion of participants, with results closely tied to total weight lost. You don’t necessarily need to follow this exact program, but the principle is clear: a substantial calorie deficit, sustained long enough to produce meaningful weight loss, is what drives the metabolic changes.
Any dietary approach that creates a large enough energy deficit can work. Some people achieve this through very low-carbohydrate diets, others through structured meal replacements, others through intermittent fasting. The specifics matter less than the outcome: enough weight loss to clear fat from the liver and pancreas.
How Exercise Improves Insulin Sensitivity
Exercise doesn’t just burn calories. It directly improves your body’s ability to use insulin, and this effect kicks in fast. Even a single session of low-intensity aerobic exercise lasting 60 minutes or more enhances insulin action for at least 24 hours in people who are overweight and insulin resistant. Shorter sessions of about 20 minutes can produce the same benefit if you push the intensity higher, incorporating bursts of near-maximal effort.
The American Diabetes Association recommends at least 150 minutes per week of moderate-to-vigorous activity, spread across at least three days. The key rule is to never let more than two consecutive days pass without exercise, because the insulin-sensitizing effect fades after about 48 hours. Aim for roughly 30 minutes on most days. On top of that, two to three sessions per week of resistance exercise (weight training, resistance bands, bodyweight exercises) on nonconsecutive days provides additional benefit by building muscle tissue, which acts as a major sink for blood glucose.
If daily moderate exercise sounds like a lot, keep in mind that the bar for “moderate” is lower than most people think. A brisk walk counts. So does cycling, swimming, or vigorous yard work.
Metabolic Surgery
For people with more severe obesity or those who haven’t achieved remission through lifestyle changes alone, bariatric surgery produces the highest remission rates of any intervention. Five-year data from a large comparative study showed that gastric bypass achieved remission in about 86% of patients, while sleeve gastrectomy reached about 84%. Gastric bypass produced slightly more weight loss and a somewhat larger reduction in HbA1c over five years.
The catch is durability. Among those who initially achieved remission, relapse rates at five years were 33% for gastric bypass and 42% for sleeve gastrectomy. Surgery is not a permanent fix for everyone, but even among those who relapse, blood sugar control typically remains better than it was before the procedure. The surgery works partly through weight loss and partly through changes in gut hormones that improve insulin secretion and sensitivity independent of weight.
Can Medications Alone Produce Remission?
Newer injectable medications that mimic a gut hormone called GLP-1 have generated enormous interest for their weight-loss effects. The question of whether they can produce true remission, meaning blood sugar stays controlled after you stop taking the drug, is more complicated. In a large observational study, only about 5.8% of patients starting GLP-1 medications achieved remission by the strictest definition (HbA1c below 6.5% for at least three months off all diabetes drugs). When the definition was loosened to include people still taking the medication, rates rose to about 18%.
The median duration of strict remission was only about five to six months. This suggests that for most people, these medications control diabetes effectively while you’re taking them but don’t fundamentally reset the underlying metabolic problem the way substantial weight loss can. They’re powerful tools, especially for people who struggle to lose weight through diet and exercise alone, but they’re better understood as ongoing treatment than as a path to medication-free remission.
Type 1 Diabetes: A Different Situation
Type 1 diabetes is an autoimmune disease in which the immune system destroys the insulin-producing cells of the pancreas. No amount of weight loss, diet change, or exercise can reverse this process. People with Type 1 diabetes require insulin to survive, and current treatment still can’t fully replicate the body’s natural insulin regulation. About 6% of people with Type 1 experience recurrent episodes of dangerously low blood sugar that put their lives at immediate risk.
That said, the field is closer to a functional cure than it has ever been. In June 2023, the FDA approved the first cell-based therapy for Type 1 diabetes: transplanted insulin-producing cells isolated from deceased donors. In clinical trials, 67% of recipients were free from insulin injections one year after their last transplant. The limitation is donor scarcity and the need for lifelong immune-suppressing drugs to prevent the body from rejecting the transplanted cells.
Stem cell-derived alternatives are further along than most people realize. An experimental therapy called VX-880 uses lab-grown insulin-producing cells derived from stem cells. In a phase 1/2 trial, all 12 patients who received a full dose showed the transplanted cells engrafting and producing insulin in response to blood sugar by day 90. Eleven of the 12 significantly reduced or completely eliminated their need for injected insulin. A related product, VX-264, encapsulates the same cells inside a protective device implanted surgically, potentially eliminating the need for immune-suppressing drugs. That trial is expected to wrap up in 2026.
These are not widely available treatments yet. But for people with Type 1 diabetes, they represent a realistic path toward something that has never existed before: a one-time procedure that restores the body’s ability to regulate its own blood sugar.